Amneal Pharmaceuticals (AMRX) Net Income Attributable to Noncontrolling Interests (2017 - 2026)
Amneal Pharmaceuticals (AMRX) posted Net Income Attributable to Noncontrolling Interests of $19.76 million for Q3 2026, up 25.4% from $15.76 million a year earlier and up 65.3% from the prior quarter.
Amneal Pharmaceuticals (AMRX) Net Income Attributable to Noncontrolling Interests (2017 - 2026) Analysis & Trends
For the trailing twelve months through Sep 30, 2026, Net Income Attributable to Noncontrolling Interests at Amneal Pharmaceuticals was $61.96 million, up 19.8% year-over-year; for FY2025, it was $55.88 million, up 29.9% from FY2024.
- In prior years, Amneal Pharmaceuticals' Net Income Attributable to Noncontrolling Interests was $43.01 million in FY2024 (+21.9%), $35.27 million in FY2023, -$125.24 million in FY2022 and $9.55 million in FY2021.
- The Q3 2026 figure stands as the highest quarterly Net Income Attributable to Noncontrolling Interests in data going back to Q2 2017.
- On a year-over-year basis, Net Income Attributable to Noncontrolling Interests increased in seven of the last eight quarters, with growth averaging 32.1%.
- The strongest year-over-year quarter for Net Income Attributable to Noncontrolling Interests in the past five years was Q4 2024, with growth of 94.9%; the weakest was Q2 2024, with a decline of 39.2%.
- According to Business Quant data, Net Income Attributable to Noncontrolling Interests for the three prior quarters was $11.95 million (Q2 2026), $15.74 million (Q1 2026) and $14.5 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCI Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,276.89 Bn | 1,250.50 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 681.31 Bn | 601.18 Bn | 17.30 Bn | - |
| 3 | AbbVie | 520.63 Bn | 488.64 Bn | 13.12 Bn | 2.00 Mn |
| 4 | Merck | 357.22 Bn | 320.16 Bn | 13.19 Bn | 2.00 Mn |
| 5 | Novartis Ag | 310.90 Bn | 284.14 Bn | - | - |
| 6 | Astrazeneca | 285.12 Bn | 258.77 Bn | 13.26 Bn | -1.00 Mn |
| 7 | Amgen | 250.23 Bn | 201.89 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 207.56 Bn | 182.67 Bn | 6.73 Bn | - |
| 9 | Pfizer | 164.42 Bn | 111.77 Bn | 12.56 Bn | 10.00 Mn |
| 10 | Amneal Pharmaceuticals | 7.10 Bn | 6.33 Bn | 334.12 Mn | 19.76 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 19.76 Mn |
| Jun 30, 2026 | 11.95 Mn |
| Mar 31, 2026 | 15.74 Mn |
| Dec 31, 2025 | 14.50 Mn |
| Sep 30, 2025 | 15.76 Mn |
| Jun 30, 2025 | 13.19 Mn |
| Mar 31, 2025 | 12.42 Mn |
| Dec 31, 2024 | 10.34 Mn |
| Sep 30, 2024 | 11.91 Mn |
| Jun 30, 2024 | 10.79 Mn |
| Mar 31, 2024 | 9.97 Mn |
| Dec 31, 2023 | 5.31 Mn |
| Sep 30, 2023 | 15.35 Mn |
| Jun 30, 2023 | 17.77 Mn |
| Mar 31, 2023 | -3.15 Mn |
| Dec 31, 2022 | -1.53 Mn |
| Sep 30, 2022 | 299,000.00 |
| Jun 30, 2022 | -119.27 Mn |
| Mar 31, 2022 | -4.74 Mn |
| Dec 31, 2021 | -14.08 Mn |
Amneal Pharmaceuticals Net Income Attributable to Noncontrolling Interests API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=AMRX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-non-controlling-interests", "ticker": "AMRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=AMRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();